890849-78-2 Usage
Uses
Used in Pharmaceutical Industry:
1-N-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYLALLYL)-PIPERIDINE is used as a building block for the synthesis of pharmaceuticals and other biologically active compounds. Its unique structure and functional groups make it a valuable intermediate in the preparation of various chemical products, contributing to the development of new drugs and therapeutic agents.
Used in Organic Synthesis:
In the field of organic synthesis, 1-N-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYLALLYL)-PIPERIDINE is utilized as a key intermediate for the creation of complex organic molecules. Its presence of protecting groups and functional groups allows for selective reactions and the formation of diverse chemical entities, expanding the scope of synthetic chemistry.
Used in Research and Development:
1-N-BOC-4-(3-CBZ-AMINO-3-METHOXYCARBONYLALLYL)-PIPERIDINE is also employed in research and development settings, where its unique properties are explored for potential applications in new chemical processes or as a precursor to novel compounds with specific biological activities. Its versatility in synthesis makes it an important tool for scientists working on the frontiers of chemical and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 890849-78-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,0,8,4 and 9 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 890849-78:
(8*8)+(7*9)+(6*0)+(5*8)+(4*4)+(3*9)+(2*7)+(1*8)=232
232 % 10 = 2
So 890849-78-2 is a valid CAS Registry Number.
InChI:InChI=1/C23H32N2O6/c1-23(2,3)31-22(28)25-14-12-17(13-15-25)10-11-19(20(26)29-4)24-21(27)30-16-18-8-6-5-7-9-18/h5-9,11,17H,10,12-16H2,1-4H3,(H,24,27)/b19-11+
890849-78-2Relevant academic research and scientific papers
COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
-
Page/Page column 24-25, (2008/12/08)
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.
COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTlVATING PROTEASE INHIBITORS
-
Page/Page column 26-27, (2008/12/08)
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating channel activating proteases, and methods for, using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSS11E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.
